Cells IA, as the technology company of the ROVI Group, will take part in the new collaboration framework established with the Government of Castilla-La Mancha to explore the use of digital solutions and artificial intelligence in the healthcare field.

This collaboration is part of the signing of a Protocol of Intent between Laboratorios Farmacéuticos ROVI, S.A. and the Government of Castilla-La Mancha, through the Regional Ministry of Finance, Public Administration and Digital Transformation. The agreement will make it possible to identify potential lines of work linked to the digital transformation of regional public healthcare and to the development of technological initiatives with applications in clinical settings.

A further step in the connection between technology and the healthcare system

The Protocol provides for ROVI's incorporation into the Regional Digital Innovation Centre, an environment aimed at fostering collaboration between institutions, companies and technology stakeholders on digitalisation and innovation projects.

In this context, Cells IA will contribute its experience in developing artificial intelligence solutions applied to clinical processes, especially in the area of anatomic pathology. Its involvement will focus on exploring collaboration opportunities that can align with the needs of the Castilla-La Mancha Health Service (SESCAM), always from a standpoint of evaluation, safety and clinical usefulness.

For Cells IA, this advance represents an opportunity to keep bringing technological innovation closer to real clinical practice, from a responsible perspective and in coordination with healthcare professionals.

Artificial intelligence as support for healthcare professionals

Applying artificial intelligence in healthcare requires a rigorous working framework, especially when it is linked to complex clinical processes. For this reason, Cells IA works on developing tools designed to support the professional, not to replace medical judgement.

In anatomic pathology, the digitalisation of samples and computational analysis open up new possibilities to support the specialist's work, facilitate the management of digital images and contribute to more structured and traceable workflows.

Cells IA's approach is based on progressing gradually, with solutions that are measurable, that can be integrated into the clinical environment and that are aligned with the standards required in the healthcare field.

“At Cells IA we work to apply artificial intelligence in a responsible and measurable way in clinical processes, especially in anatomic pathology. This Protocol opens the door to collaborating with SESCAM on the joint validation and evaluation of tools that can be integrated into clinical practice with guarantees, providing support to the professional and contributing to the continuous improvement of workflows,” says Ignacio Jiménez-Carlés, Director of Operations and Business Development at Cells IA.

Digital anatomic pathology and clinical validation

Anatomic pathology plays an essential role in the diagnosis of many conditions. The shift towards digital environments makes it possible to work with high-resolution images and opens the door to using algorithms designed to support specific tasks within the diagnostic workflow.

In this field, Cells IA develops medical software platforms and artificial intelligence models geared towards the analysis of digital images, with particular attention to clinical validation, traceability and integration with the processes already in place in hospitals and laboratories.

Healthcare innovation based on collaboration and evidence

Digital transformation in healthcare does not depend on technology alone. It requires collaboration between public institutions, specialised companies, clinical teams and innovation centres capable of assessing each advance against technical, clinical and regulatory criteria.

From this perspective, Cells IA will continue working to ensure that artificial intelligence can be incorporated responsibly into clinical processes, with tools designed to provide support to healthcare professionals and contribute to a safe evolution of digital anatomic pathology.

Cells IA's involvement in this collaboration framework reinforces its commitment to healthcare innovation based on evidence, joint evaluation and the practical application of technology for the benefit of health systems.

About Cells IA

CellsIA is a technology company within the ROVI Group specialising in the development of digital health solutions and artificial intelligence applied to clinical diagnosis. The company develops medical software platforms and advanced algorithms for the analysis of digital images, with a particular focus on anatomic pathology and precision diagnosis, helping to improve the efficiency of clinical processes and the diagnostic capacity of healthcare professionals.

With an international presence and a clear focus on innovation, CellsIA works in collaboration with hospitals, clinical professionals and research centres to drive the adoption of advanced technologies in clinical practice, fostering more efficient and sustainable medicine.